Stockreport

Intellia seeks FDA approval for in vivo CRISPR therapy [Yahoo! Finance]

DHI Group, Inc.  (DHX) 
Last dhi group, inc. earnings: 2/5 04:15 pm Check Earnings Report
US:NYSE Investor Relations: dhigroupinc.com/investors/default.aspx
PDF treatment for hereditary angioedema that would become the first in vivo CRISPR-based gene editing therapy if cleared by regulators. Positive Phase 3 HAELO trial result [Read more]